Navigation Links
Favrille Reports Fourth Quarter and Year End 2007 Financial Results
Date:2/19/2008

facturing technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Favrille's product candidates, proprietary technologies and research programs. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Favrille's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, risks and uncertainties related to Favrille's ability to fund operations through the primary endpoint analysis of its Phase 3 clinical registration trial progress and timing of clinical trials for Specifid, including difficulties or delays in development, testing, manufacturing and marketing Specifid or Favrille's other product candidates; delays in the availability of data from Favrille's Phase 3 clinical trial; Favrille's ability to obtain marketing approval for Specifid or Favrille's other product candidates and the timing of any such approvals, including whether a clinically meaningful response improvement can serve as the basis for accelerated approval of Specifid and whether it will receive expedited review as a result of the Fast Track designation; Favrille's ability to demonstrate that its idiotype protein produced from insect cell lines may stimulate a more effective immune response compared to idiotype protein derived from mammalian cells; Favrille's ability to manufacture sufficient quantities of Specifid for use in clinical trials and, if Specifid receives marketing approval, for commercialization; risks associated with achieving projected operating metrics and financial performance or the anticipated number of patients using Specifid; potential delays in patient enrollme
'/>"/>

SOURCE Favrille, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Favrille Announces $21.1 Million Registered Direct Offering
2. Favrille to Present at BIOCOM Investor Conference, Acumen BioFin Rodman & Renshaw Healthcare Conference and CIBC World Markets Healthcare Conference
3. Favrille to Host Conference Call and Live Webcast to Discuss Third Quarter 2007 Financial Results on October 25, 2007
4. Favrille to Present at BIO InvestorForum
5. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
6. Favrille CEO to Present at Bear Stearns Healthcare Conference
7. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
8. JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis
9. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
10. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
11. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 Results from a ... laherparepvec and its ability to reduce the size of ... been published in the Journal of Clinical Oncology. ... stages IIIB, IIIC and IV melanoma, a potentially fatal ... study was to evaluate the safety and efficacy of ...
(Date:5/28/2015)... May 28, 2015  Quest Diagnostics Incorporated (NYSE: ... services, announced that it is scheduled to speak at ... Steve Rusckowski , the company,s President and CEO, ... strategy.  The presentation is scheduled for Tuesday, June 2, ... presentation will be webcast live during the conference and ...
(Date:5/28/2015)... , May 27, 2015 Research ... of Jain PharmaBiotech,s new report "Neuroprotection - ... This report describes the role of ... injuries of the nervous system as well as ... many of the underlying mechanisms of damage to ...
(Date:5/28/2015)... TX (PRWEB) May 28, 2015 ... association serving and representing the life sciences industry ... Board of Directors meeting at The Foundry in ... of the organization brought together a broad spectrum ... and underscored the organization's early successes in partnering ...
Breaking Biology Technology:Study Published in Journal of Clinical Oncology Reports Talimogene Laherparepvec Improvesdurable Responses in Patients with Advanced Melanoma 2Quest Diagnostics to Speak at the Jefferies 2015 Global Healthcare Conference 2Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 2Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 3BioNorthTX Holds Inaugural Board of Directors Meeting 2BioNorthTX Holds Inaugural Board of Directors Meeting 3
... for the faint of heart. Global competition and offshore manufacturing ... with rising unemployment, the need to retrain workers, and a ... for new ways to survive and grow. , ,If ... Dr. Raj Veeramani, UW Professor of Engineering and Business and ...
... O'Malley, D.O. established his practice, O'Malley Family Medicine, ... that practicing ndependently would enable him to provide ... a solo practitioner build a thriving practice in ... essential," says O'Malley. "That's why I sought to ...
... of Wisconsin and Delta Dental Plan of New Jersey ... made by Aetna, Ameritas Life Insurance Corp., Delta Dental ... America, MetLife and Dental Benefit Providers (the dental subsidiary ... in a cooperative technology venture to enhance a platform ...
Cached Biology Technology:University Consortium Enables Transformation and Survival for Wisconsin Businesses 2University Consortium Enables Transformation and Survival for Wisconsin Businesses 3Computer Card Supports Solo Doctor 2
(Date:5/6/2015)... AVIV, Israel , May 6, 2015 ... world,s most established helmet producer, announced today that they ... Smart Helmet, the world,s first bio-sensing cycling helmet and ... be released in two new colors in order to ... for the product. In addition, LifeBEAM and Lazer announced ...
(Date:4/21/2015)... High crime rate, increasing ... access control systems market in Saudi Arabia ... published report by TechSci Research " Saudi Arabia Access Control ... systems market in Saudi Arabia ... control systems market in the Kingdom is growing at ...
(Date:4/14/2015)... April 14, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... the 2015 New York Design Awards under the category  ... York City Design Awards are part of a global ... 2,500 ratings from the marketplace, industry and judging panel. ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... Hughes Medical Institute researchers have discovered that pheromones essential ... nose and not by the vomeronasal system, as researchers ... olfactory epithelium, which was presumed to be mostly involved ... in pheromone detection. , Howard Hughes Medical Institute ...
... Alejandro Toledo Arana has identified two new genes that ... biofilm of Staphylococcus aureus , one of the ... and has explained the functioning of a structural protein ... of a PhD thesis recently defended at the Institute ...
... bacterial riboswitches may be a good hunting ground for ... by Yale researchers in the journal Chemistry and Biology. ... in essential metabolic pathways. Researchers in the laboratory of ... Professor of Molecular, Cellular and Developmental Biology ...
Cached Biology News:Olfactory system detects pheromones that control reproduction 2Olfactory system detects pheromones that control reproduction 3Olfactory system detects pheromones that control reproduction 4Genes involved in biofilms 2Switching to new anti-bacterial targets: Riboswitches 2
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
...
Rat Aortic Smooth Muscle Cells (RAOSMC) (>500,000 cells)...
... ideal small concentrator for the molecular biology ... water and organic solvents from a variety ... and round bottom flasks. Making it an ... ,The built-in special runs for working with ...
Biology Products: